Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Next-Generation CRISPR Technologies and Their Applications in Gene and Cell Therapy
M. Alejandra Zeballos C., Thomas Gaj
Trends in biotechnology (2020) Vol. 39, Iss. 7, pp. 692-705
Open Access | Times Cited: 70

Showing 1-25 of 70 citing articles:

Current understanding of osteoarthritis pathogenesis and relevant new approaches
Liping Tong, Huan Yu, Xingyun Huang, et al.
Bone Research (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 231
CRISPR/Cas: a Nobel Prize award-winning precise genome editing technology for gene therapy and crop improvement
Chao Li, Eleanor J. Brant, Hikmet Budak, et al.
Journal of Zhejiang University SCIENCE B (2021) Vol. 22, Iss. 4, pp. 253-284
Open Access | Times Cited: 134
Highly efficient prime editing by introducing same-sense mutations in pegRNA or stabilizing its structure
Xiaosa Li, Lina Zhou, Bao‐Qing Gao, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 102
Exosomes as Targeted Delivery Platform of CRISPR/Cas9 for Therapeutic Genome Editing
Li Duan, Kan Ouyang, Jianhong Wang, et al.
ChemBioChem (2021) Vol. 22, Iss. 24, pp. 3360-3368
Closed Access | Times Cited: 66
Deliver the promise: RNAs as a new class of molecular entities for therapy and vaccination
Ai‐Ming Yu, Mei‐Juan Tu
Pharmacology & Therapeutics (2021) Vol. 230, pp. 107967-107967
Open Access | Times Cited: 66
CRISPR-Cas13 System as a Promising and Versatile Tool for Cancer Diagnosis, Therapy, and Research
Fahreddin Palaz, Ali Kerem Kalkan, Özgür Can, et al.
ACS Synthetic Biology (2021) Vol. 10, Iss. 6, pp. 1245-1267
Closed Access | Times Cited: 63
Highly efficient generation of isogenic pluripotent stem cell models using prime editing
Hanqin Li, Oriol Busquets, Yogendra Verma, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 44
CRISPR innovations in tissue engineering and gene editing
ZahraSadat Razavi, M. Soltani, Mohammad Souri, et al.
Life Sciences (2024), pp. 123120-123120
Open Access | Times Cited: 10
CRISPR-Cas9 Targeting PCSK9: A Promising Therapeutic Approach for Atherosclerosis
Bin Gu, Man Li, Dan Li, et al.
Journal of Cardiovascular Translational Research (2025)
Closed Access | Times Cited: 1
Mitigating a TDP-43 proteinopathy by targeting ataxin-2 using RNA-targeting CRISPR effector proteins
M. Alejandra Zeballos C., Hayden J. Moore, Tyler Smith, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 21
Improvement of base editors and prime editors advances precision genome engineering in plants
Kai Hua, Peijin Han, Jian‐Kang Zhu
PLANT PHYSIOLOGY (2021) Vol. 188, Iss. 4, pp. 1795-1810
Open Access | Times Cited: 38
Base editors: development and applications in biomedicine
Yanhui Liang, Fangbing Chen, Kepin Wang, et al.
Frontiers of Medicine (2023) Vol. 17, Iss. 3, pp. 359-387
Closed Access | Times Cited: 14
Smart Nanocomposite Hydrogels as Next-Generation Therapeutic and Diagnostic Solutions
Anna Valentino, Sorur Yazdanpanah, Raffaele Conte, et al.
Gels (2024) Vol. 10, Iss. 11, pp. 689-689
Open Access | Times Cited: 5
Efficient correction of ABCA4 variants by CRISPR-Cas9 in hiPSCs derived from Stargardt disease patients
Laura Siles, Sheila Ruiz‐Nogales, Arnau Navinés‐Ferrer, et al.
Molecular Therapy — Nucleic Acids (2023) Vol. 32, pp. 64-79
Open Access | Times Cited: 12
Treatment of autosomal dominant retinitis pigmentosa caused by RHO-P23H mutation with high-fidelity Cas13X in mice
Zixiang Yan, Yuqin Yao, Luyao Li, et al.
Molecular Therapy — Nucleic Acids (2023) Vol. 33, pp. 750-761
Open Access | Times Cited: 12
Impact of Chromatin Organization and Epigenetics on CRISPR-Cas and TALEN Genome Editing
Surbhi Jain, Guanhua Xun, Huimin Zhao
ACS Synthetic Biology (2024)
Closed Access | Times Cited: 4
CRISPR-Cas13 in malaria parasite: Diagnosis and prospective gene function identification
Elvis Quansah, Yihuan Chen, Shijie Yang, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 10
Potential therapeutic targets of macrophages in inhibiting immune damage and fibrotic processes in musculoskeletal diseases
Jianshu Zhu, Jiawei Fan, Yuanliang Xia, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 10
Application of CRISPR/Cas9 system in type 2 diabetes mellitus
Xinyue Zhang
Theoretical and Natural Science (2025) Vol. 82, Iss. 1, pp. 1-5
Closed Access
Unlocking DNA's Code: Proposal For New Framework Providing For Genetic Patents
Decorian Menefee
(2025)
Closed Access
Progress in Gene Therapy for Hereditary Tyrosinemia Type 1
Helen Thomas, Robert Carlisle
Pharmaceutics (2025) Vol. 17, Iss. 3, pp. 387-387
Open Access
Engineering ARMMs for improved intracellular delivery of CRISPR-Cas9
Zunwei Chen, Qiyu Wang, Quan Lu
Extracellular Vesicle (2025) Vol. 5, pp. 100082-100082
Closed Access
Enhancing Animal Disease Resistance, Production Efficiency, and Welfare through Precise Genome Editing
Zhiguo Liu, Tianwen Wu, Guangming Xiang, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 7331-7331
Open Access | Times Cited: 15
Precise mutagenesis in zebrafish using cytosine base editors
Marion Rosello, Malo Serafini, Jean‐Paul Concordet, et al.
Nature Protocols (2023) Vol. 18, Iss. 9, pp. 2794-2813
Closed Access | Times Cited: 9
Revolutionizing healthcare: the role of CRISPR-Cas systems in precision medicine
Kirolos Eskandar
Pharmacogenetics and Pharmacogenomics (2025), Iss. 2, pp. 29-36
Open Access
Page 1 - Next Page

Scroll to top